Press coverage about Smith & Nephew SNATS (NYSE:SNN) has trended somewhat positive on Wednesday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Smith & Nephew SNATS earned a news sentiment score of 0.12 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 46.7799828971578 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:
- Smith & Nephew plc: Acquisition of Rotation Medical Inc (twst.com)
- Smith & Nephew Buys Tissue Regeneration Developer Rotation Medical (nasdaq.com)
- Analyzing Smith & Nephew SNATS (SNN) and Its Peers (americanbankingnews.com)
- Uroplasty (UPI) versus Smith & Nephew SNATS (SNN) Financial Analysis (americanbankingnews.com)
- Critical Comparison: Smith & Nephew SNATS (SNN) and Its Rivals (americanbankingnews.com)
Shares of Smith & Nephew SNATS (SNN) traded up $0.04 during mid-day trading on Wednesday, hitting $35.95. The stock had a trading volume of 276,764 shares, compared to its average volume of 494,509. The company has a current ratio of 2.18, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. Smith & Nephew SNATS has a fifty-two week low of $28.45 and a fifty-two week high of $40.43.
WARNING: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.com-unik.info/2017/12/06/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-smith-nephew-snats-snn-stock-price.html.
Smith & Nephew SNATS Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
What are top analysts saying about Smith & Nephew SNATS Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Smith & Nephew SNATS Inc. and related companies.